Targeted Therapies in Oncology
December 2 2018
Volume: 7
Issue: 13
December 2018
Volume: 7
Issue: 12
November 2018
Volume: 7
Issue: 11
October 2018
Volume: 7
Issue: 10
Sept 2018
Volume: 7
Issue: 9
August 2018
Volume: 7
Issue: 8
July 2018
Volume: 7
Issue: 7
June 2018
Volume: 7
Issue: 6
May 2018
Volume: 7
Issue: 5
April 2018
Volume: 7
Issue: 4
March 2018
Volume: 7
Issue: 3
February 2018
Volume: 7
Issue: 2
January 2018
Volume: 7
Issue: 1
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Approves Subcutaneous Amivantamab for EGFR-Mutated NSCLC Indications
2
Long-Term ECHO Data Support Concurrent Acalabrutinib/BR in MCL
3
Pelareorep Offers Promise in Second-Line KRAS-Mutant Metastatic CRC
4
Phase 3 Data Highlight Orca-T’s Clinical Benefits in Heme Malignancies
5